Treatment of cancer using Anti-CD19 chimeric antigen receptor

MYPI2025005468A0Undetermined Publication Date: 2015-10-07THE TRUSTEES OF THE UNIV OF PENNSYLVANIA +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025005468
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2015-04-07
Filing Date
2015-04-07
Publication Date
2015-10-07
Patent Text Reader

Abstract

The invention provides compositions and methods for treating diseases associated with expression of CD19, e.g., by administering a recombinant T cell comprising the CD19 CAR as described herein, in combination with a kinase inhibitor, e.g., a kinase inhibitor described herein. The invention also provides kits and compositions described herein.
Need to check novelty before this filing date? Find Prior Art